During the afternoon, the DNCP published that the company La Química Farmacéutica SA was awarded for a total value of G. 9,771,580,000, and managed to win the tender for N 42/2022 “Acquisition of Medications for Triple Therapy: Elexacaftor/Tezacaftor /Ivacaftor for the National Program for the Prevention of Cystic Fibrosis and Mental Retardation» with ID 414.600. For this tender, offers began to be received on Friday, July 1, 2022.
The Ministry of Public Health and Social Welfare (MSPBS) was the institution in charge of carrying out the Call for Tenders No. 414,600 under the category of Medical and Laboratory Equipment, Products and Instruments. Health Assistance Servicesby the type of National Public Bidding procedure.
The aforementioned institution awarded 1 item.
- 196 units of Elexacaftor + Ivacaftor + Tezacaftor Tablet with a unit price of G. 49,855,000
The aforementioned firm is legally represented by Maria Eugenia Harrison de Galeano and Pio Osvaldo Galeano Rios.
The Farmacéutica Chemistry SA was the only company that appeared to the call.
Source: DNCP
